ANIP logo

ANI Pharmaceuticals (ANIP) Cash from investing

annual CFI:

-$404.72M-$386.21M(-2086.37%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual cash flow from investing activities is -$404.72 million, with the most recent change of -$386.21 million (-2086.37%) on December 31, 2024.
  • During the last 3 years, ANIP annual CFI has fallen by -$299.24 million (-283.68%).
  • ANIP annual CFI is now -2096.94% below its all-time high of $20.27 million, reached on December 31, 2013.

Performance

ANIP Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

quarterly CFI:

-$19.85M-$9.16M(-85.81%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly cash flow from investing activities is -$19.85 million, with the most recent change of -$9.16 million (-85.81%) on March 31, 2025.
  • Over the past year, ANIP quarterly CFI has dropped by -$28.78 million (-322.17%).
  • ANIP quarterly CFI is now -202.67% below its all-time high of $19.33 million, reached on June 30, 2013.

Performance

ANIP quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

TTM CFI:

-$433.50M-$28.78M(-7.11%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP TTM cash flow from investing activities is -$433.50 million, with the most recent change of -$28.78 million (-7.11%) on March 31, 2025.
  • Over the past year, ANIP TTM CFI has dropped by -$426.27 million (-5899.97%).
  • ANIP TTM CFI is now -2238.94% below its all-time high of $20.27 million, reached on December 31, 2013.

Performance

ANIP TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ANIP Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2086.4%-322.2%-5900.0%
3 y3 years-283.7%-811.2%-305.4%
5 y5 years-1369.1%+65.5%-568.9%

ANIP Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2471.6%at low-322.2%+95.0%-8841.8%at low
5 y5-year-2471.6%at low-322.2%+95.0%-8841.8%at low
alltimeall time-2096.9%at low-202.7%+95.0%-2238.9%at low

ANIP Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$19.85M(+85.8%)
-$433.50M(+7.1%)
Dec 2024
-$404.72M(+2086.4%)
-$10.68M(-97.3%)
-$404.72M(+1.5%)
Sep 2024
-
-$398.52M(+8857.6%)
-$398.82M(+8126.4%)
Jun 2024
-
-$4.45M(-149.8%)
-$4.85M(-32.9%)
Mar 2024
-
$8.93M(-286.9%)
-$7.22M(-61.0%)
Dec 2023
-$18.51M(+17.6%)
-$4.78M(+5.0%)
-$18.51M(+9.7%)
Sep 2023
-
-$4.55M(-33.3%)
-$16.87M(-23.8%)
Jun 2023
-
-$6.83M(+190.1%)
-$22.14M(+39.1%)
Mar 2023
-
-$2.35M(-25.1%)
-$15.91M(+1.1%)
Dec 2022
-$15.74M(-85.1%)
-$3.14M(-68.0%)
-$15.74M(-83.4%)
Sep 2022
-
-$9.81M(+1524.8%)
-$94.81M(+10.8%)
Jun 2022
-
-$604.00K(-72.3%)
-$85.58M(-20.0%)
Mar 2022
-
-$2.18M(-97.4%)
-$106.92M(+1.4%)
Dec 2021
-$105.48M(+54.4%)
-$82.21M(>+9900.0%)
-$105.48M(+315.5%)
Sep 2021
-
-$583.00K(-97.3%)
-$25.39M(-17.1%)
Jun 2021
-
-$21.95M(+2878.3%)
-$30.61M(+165.9%)
Mar 2021
-
-$737.00K(-65.2%)
-$11.51M(-83.1%)
Dec 2020
-$68.32M(+148.0%)
-$2.12M(-63.5%)
-$68.32M(+1.1%)
Sep 2020
-
-$5.81M(+104.0%)
-$67.58M(+6.1%)
Jun 2020
-
-$2.85M(-95.1%)
-$63.70M(-1.7%)
Mar 2020
-
-$57.55M(+4088.2%)
-$64.81M(+135.3%)
Dec 2019
-$27.55M(+0.6%)
-$1.37M(-28.9%)
-$27.55M(+3.6%)
Sep 2019
-
-$1.93M(-51.2%)
-$26.58M(-38.3%)
Jun 2019
-
-$3.96M(-80.5%)
-$43.09M(-5.1%)
Mar 2019
-
-$20.29M(+4884.0%)
-$45.39M(+65.8%)
Dec 2018
-$27.38M(-74.6%)
-$407.00K(-97.8%)
-$27.38M(-64.5%)
Sep 2018
-
-$18.44M(+194.8%)
-$77.09M(+26.1%)
Jun 2018
-
-$6.25M(+174.6%)
-$61.13M(+6.9%)
Mar 2018
-
-$2.28M(-95.5%)
-$57.18M(-47.1%)
Dec 2017
-$107.99M(-27.6%)
-$50.12M(+1920.8%)
-$107.99M(+82.2%)
Sep 2017
-
-$2.48M(+7.6%)
-$59.27M(+2.4%)
Jun 2017
-
-$2.30M(-95.7%)
-$57.88M(-50.4%)
Mar 2017
-
-$53.09M(+3722.5%)
-$116.60M(-21.8%)
Dec 2016
-$149.06M(+356.1%)
-$1.39M(+27.5%)
-$149.06M(+0.2%)
Sep 2016
-
-$1.09M(-98.2%)
-$148.78M(-14.7%)
Jun 2016
-
-$61.03M(-28.7%)
-$174.46M(+53.5%)
Mar 2016
-
-$85.55M(+7642.2%)
-$113.62M(+247.6%)
Dec 2015
-$32.68M(-8.6%)
-$1.10M(-95.9%)
-$32.68M(+2.4%)
Sep 2015
-
-$26.77M(>+9900.0%)
-$31.92M(+15.3%)
Jun 2015
-
-$198.00K(-95.7%)
-$27.68M(-0.2%)
Mar 2015
-
-$4.61M(+1264.5%)
-$27.73M(-22.4%)
Dec 2014
-$35.75M(-276.4%)
-$338.00K(-98.5%)
-$35.75M(+7.7%)
Sep 2014
-
-$22.53M(+8804.3%)
-$33.19M(+210.4%)
Jun 2014
-
-$253.00K(-98.0%)
-$10.69M(-220.2%)
Mar 2014
-
-$12.63M(-666.3%)
$8.89M(-56.1%)
Dec 2013
$20.27M(-3373.6%)
$2.23M(-6661.8%)
$20.27M(+12.9%)
Sep 2013
-
-$34.00K(-100.2%)
$17.95M(+2.5%)
Jun 2013
-
$19.33M(-1634.0%)
$17.52M(-1064.3%)
Mar 2013
-
-$1.26M(+1427.4%)
-$1.82M(+193.5%)
Dec 2012
-$619.10K
-$82.50K(-82.3%)
-$619.20K(+1.3%)
Sep 2012
-
-$465.40K(+5014.3%)
-$611.00K(+146.1%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$9100.00(-85.4%)
-$248.30K(-55.7%)
Mar 2012
-
-$62.20K(-16.3%)
-$560.90K(-22.1%)
Dec 2011
-$719.90K(+1091.9%)
-$74.30K(-27.7%)
-$719.90K(+6.0%)
Sep 2011
-
-$102.70K(-68.1%)
-$679.30K(+17.2%)
Jun 2011
-
-$321.70K(+45.4%)
-$579.50K(+111.7%)
Mar 2011
-
-$221.20K(+556.4%)
-$273.80K(+353.3%)
Dec 2010
-$60.40K(-102.1%)
-$33.70K(+1062.1%)
-$60.40K(+54.9%)
Sep 2010
-
-$2900.00(-81.9%)
-$39.00K(+6.0%)
Jun 2010
-
-$16.00K(+105.1%)
-$36.80K(+76.9%)
Mar 2010
-
-$7800.00(-36.6%)
-$20.80K(-100.7%)
Dec 2009
$2.86M(-74.7%)
-$12.30K(+1657.1%)
$2.86M(-75.0%)
Sep 2009
-
-$700.00(<-9900.0%)
$11.45M(-7.8%)
Jun 2009
-
$0.00(-100.0%)
$12.41M(-13.1%)
Mar 2009
-
$2.87M(-66.5%)
$14.28M(+26.1%)
Dec 2008
$11.33M(-200.8%)
$8.58M(+791.0%)
$11.33M(-236.1%)
Sep 2008
-
$962.80K(-48.5%)
-$8.32M(-10.8%)
Jun 2008
-
$1.87M(-2361.1%)
-$9.34M(-17.1%)
Mar 2008
-
-$82.70K(-99.3%)
-$11.26M(+0.2%)
Dec 2007
-$11.24M(-326.8%)
-$11.07M(>+9900.0%)
-$11.24M(-289.1%)
Sep 2007
-
-$49.90K(-7.2%)
$5.94M(+1296.7%)
Jun 2007
-
-$53.80K(-11.8%)
$425.50K(-86.2%)
Mar 2007
-
-$61.00K(-101.0%)
$3.09M(-37.7%)
Dec 2006
$4.96M(-31.6%)
$6.11M(-209.7%)
$4.96M(+6025.7%)
Sep 2006
-
-$5.57M(-313.3%)
$80.90K(-98.9%)
Jun 2006
-
$2.61M(+44.5%)
$7.29M(-4.9%)
Mar 2006
-
$1.81M(+46.5%)
$7.67M(+5.9%)
Dec 2005
$7.24M(-144.7%)
$1.23M(-25.1%)
$7.24M(+276.3%)
Sep 2005
-
$1.65M(-44.9%)
$1.92M(-116.3%)
Jun 2005
-
$2.98M(+116.6%)
-$11.78M(-20.4%)
Mar 2005
-
$1.38M(-133.7%)
-$14.79M(-8.7%)
Dec 2004
-$16.20M(>+9900.0%)
-$4.08M(-66.1%)
-$16.20M(+33.6%)
Sep 2004
-
-$12.06M(>+9900.0%)
-$12.12M(>+9900.0%)
Jun 2004
-
-$31.90K(+5.3%)
-$71.10K(+81.4%)
Mar 2004
-
-$30.30K(+604.7%)
-$39.20K(+340.4%)
Dec 2003
-$8900.00(-77.2%)
-$4300.00(-6.5%)
-$8900.00(+1.1%)
Sep 2003
-
-$4600.00(<-9900.0%)
-$8800.00(-33.3%)
Jun 2003
-
$0.00(0.0%)
-$13.20K(-41.1%)
Mar 2003
-
$0.00(-100.0%)
-$22.40K(-42.6%)
Dec 2002
-$39.00K(-55.0%)
-$4200.00(-53.3%)
-$39.00K(-13.7%)
Sep 2002
-
-$9000.00(-2.2%)
-$45.20K(-49.8%)
Jun 2002
-
-$9200.00(-44.6%)
-$90.00K(-11.1%)
Mar 2002
-
-$16.60K(+59.6%)
-$101.20K(+16.7%)
Dec 2001
-$86.70K(+100.7%)
-$10.40K(-80.7%)
-$86.70K(-1.5%)
Sep 2001
-
-$53.80K(+163.7%)
-$88.00K(+129.2%)
Jun 2001
-
-$20.40K(+871.4%)
-$38.40K(+12.9%)
Mar 2001
-
-$2100.00(-82.1%)
-$34.00K(-21.3%)
Dec 2000
-$43.20K(+928.6%)
-$11.70K(+178.6%)
-$43.20K(+37.1%)
Sep 2000
-
-$4200.00(-73.8%)
-$31.50K(+15.4%)
Jun 2000
-
-$16.00K(+41.6%)
-$27.30K(+141.6%)
Mar 2000
-
-$11.30K
-$11.30K
Dec 1999
-$4200.00(-96.6%)
-
-
Dec 1998
-$125.00K
-
-

FAQ

  • What is ANI Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual CFI year-on-year change?
  • What is ANI Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly CFI year-on-year change?
  • What is ANI Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM CFI year-on-year change?

What is ANI Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of ANIP is -$404.72M

What is the all time high annual CFI for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual cash flow from investing activities is $20.27M

What is ANI Pharmaceuticals annual CFI year-on-year change?

Over the past year, ANIP annual cash flow from investing activities has changed by -$386.21M (-2086.37%)

What is ANI Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of ANIP is -$19.85M

What is the all time high quarterly CFI for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly cash flow from investing activities is $19.33M

What is ANI Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, ANIP quarterly cash flow from investing activities has changed by -$28.78M (-322.17%)

What is ANI Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of ANIP is -$433.50M

What is the all time high TTM CFI for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM cash flow from investing activities is $20.27M

What is ANI Pharmaceuticals TTM CFI year-on-year change?

Over the past year, ANIP TTM cash flow from investing activities has changed by -$426.27M (-5899.97%)
On this page